Back

NT-proBNP as a prognostic biomarker in acute de novo heart failure: insights from the COMFE registry

19 May 2025 (14:20 - 15:40)
Organised by: Logo
Congress Presentation Part of: ePosters in chronic heart failure - biomarkers (2) Biomarkers HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Mr Oscar Otero Garcia

University Hospital of Santiago de Compostela, Santiago de Compostela (Spain)

5 More presentations in this session

Presentation thumbnail
The association between the neutrophil-to-lymphocyte ratio and the risk of chronic heart failure in obese patients following myocardial infarction
Doctor A. Kobets (Kharkiv, UA)
Abstract Slides Video
Presentation thumbnail
B-type natriuretic peptide predicts mortality in patients with acute ischemic stroke
Professor K. Hong (Chuncheon, KR)
Abstract Slides Video
Presentation thumbnail
The role of CA125 as a congestion biomarker in ischemic heart failure
Doctor M. Paralta De Figueiredo (Evora, PT)
Abstract Slides Video
Presentation thumbnail
CRP: a game-changer in predicting adverse cardiovascular events in hospitalized patients?
Doctor R. Gonzalez Mayo (Ciudad De Mexico, MX) Miss M. Bejarano Vergara (MX)
Abstract Slides Video
Presentation thumbnail
Does change in natriuretic peptide indicate clinically meaningful change in heart failure status in stable heart failure?
Doctor G. Bruno (Limerick, IE)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in chronic heart failure - biomarkers (2)

The Event

Event poster

Heart Failure 2025

19 May 2025 14:20 CET
You may be interested in
thumbnail
Congress Presentation
What factors are associated with myocardial recovery following admission for acute heart failure? Study in patients with de novo diagnosis and reduced left ventricular ejection fraction
thumbnail
Congress Presentation
Prognosis and NT-proBNP decrease in heart failure patients from admission to follow up
thumbnail
Congress Presentation
NT-proBNP at day 4 of hospitalization: a single prognostic marker for prediction of both in-hospital and post-discharge outcomes in acute heart failure with reduced ejection fraction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources